Literature DB >> 28292540

Reactive Arthritis.

Steven K Schmitt1.   

Abstract

Reactive arthritis is classified as a spondyloarthropathy. Current concepts of disease suggest an infectious trigger, followed by inflammatory arthritis. Several mechanisms have been proposed to explain the interaction of host susceptibility and microorganism. Diagnosis relies on a compatible clinical syndrome and microbiologic confirmation of the pathogen. Antibiotic therapy seems useful in Chlamydia-triggered arthritis. The role of antibiotics in arthritis triggered by enteric pathogens is less clear. The role of tumor necrosis factor alpha inhibitors in therapy is evolving. Many patients have a course limited to a few months, but others experience extraarticular disease and more prolonged courses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Campylobacter; Chlamydia; Inflammatory arthritis; Reactive arthritis; Salmonella; Shigella; Spondyloarthropathy; Yersinia

Mesh:

Substances:

Year:  2017        PMID: 28292540     DOI: 10.1016/j.idc.2017.01.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  33 in total

Review 1.  The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

Authors:  C Vitulano; V Tedeschi; F Paladini; R Sorrentino; M T Fiorillo
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

Review 2.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

3.  Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

Authors:  Riitta Tuompo; Timo Hannu; Elisa Huovinen; Leila Sihvonen; Anja Siitonen; Marjatta Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2017-09-16       Impact factor: 2.631

4.  Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.

Authors:  Helga Raquel Garcia Ferrer; Alexander Azan; Isa Iraheta; Joan Von Feldt; Luis R Espinoza; Julia Manasson; Jose U Scher; Abraham Garcia Kutzbach; Alexis Ogdie
Journal:  Clin Rheumatol       Date:  2017-11-14       Impact factor: 2.980

Review 5.  Chlamydia-Induced Reactive Arthritis: Disappearing Entity or Lack of Research?

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.592

6.  First description of reactive arthritis secondary to leptospirosis in a dog.

Authors:  T Furlanello; I Reale
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

7.  Bilateral sacroiliitis following group C streptococcal sepsis.

Authors:  Sanjeev Shrestha; Eva Rottmann; Prakash Kharel; Francis Lim; David Henry Bulbin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-03-09

Review 8.  Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.

Authors:  Blas Y Betancourt; Ann Biehl; James D Katz; Ananta Subedi
Journal:  Rheum Dis Clin North Am       Date:  2018-06-12       Impact factor: 2.670

Review 9.  Polyarthritis and its differential diagnosis.

Authors:  Nilüfer Alpay-Kanıtez; Selda Çelik; Cemal Bes
Journal:  Eur J Rheumatol       Date:  2018-10-01

Review 10.  Is Non-Chlamydial Non-Gonococcal Urethritis Associated with Significant Clinical Complications in Men? A Systematic Review.

Authors:  Cassandra E L Fairhead; Alexander Hampson; Louis Dwyer-Hemmings; Nikhil Vasdev
Journal:  Curr Urol       Date:  2020-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.